MEDIPOST Co. Ltd (078160) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.054x

Based on the latest financial reports, MEDIPOST Co. Ltd (078160) has a cash flow conversion efficiency ratio of -0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-14.44 Billion ≈ $-9.78 Million USD) by net assets (₩265.17 Billion ≈ $179.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

MEDIPOST Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how MEDIPOST Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does MEDIPOST Co. Ltd carry for a breakdown of total debt and financial obligations.

MEDIPOST Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MEDIPOST Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Vardhman Special Steels Limited NSE:VSSL	0.059x
BMTC Group Inc TO:GBT	0.006x
High Liner Foods Incorporated TO:HLF	-0.061x
Kaimei Electronic Corp TW:2375	0.007x
Ho Tung Chemical Corp TW:1714	-0.013x
Odfjell Technology Ltd OL:OTL	0.083x
EPACK Durable Limited NSE:EPACK	N/A
Anhui Provincial Architectural Design and Research Institute Co.Ltd. SHE:301167	N/A

Annual Cash Flow Conversion Efficiency for MEDIPOST Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of MEDIPOST Co. Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see MEDIPOST Co. Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩252.60 Billion ≈ $171.18 Million	₩-37.27 Billion ≈ $-25.25 Million	-0.148x	-142.55%
2023-12-31	₩313.66 Billion ≈ $212.56 Million	₩-19.08 Billion ≈ $-12.93 Million	-0.061x	-76.79%
2022-12-31	₩179.97 Billion ≈ $121.96 Million	₩-6.19 Billion ≈ $-4.20 Million	-0.034x	-235.26%
2021-12-31	₩159.48 Billion ≈ $108.08 Million	₩4.06 Billion ≈ $2.75 Million	0.025x	+66.11%
2020-12-31	₩116.54 Billion ≈ $78.98 Million	₩1.78 Billion ≈ $1.21 Million	0.015x	-77.26%
2019-12-31	₩111.59 Billion ≈ $75.62 Million	₩7.51 Billion ≈ $5.09 Million	0.067x	+23.88%
2018-12-31	₩126.81 Billion ≈ $85.94 Million	₩6.89 Billion ≈ $4.67 Million	0.054x	+181.97%
2017-12-31	₩104.45 Billion ≈ $70.78 Million	₩-6.93 Billion ≈ $-4.69 Million	-0.066x	+23.49%
2016-12-31	₩143.31 Billion ≈ $97.12 Million	₩-12.42 Billion ≈ $-8.42 Million	-0.087x	-83.84%
2015-12-31	₩146.48 Billion ≈ $99.27 Million	₩-6.91 Billion ≈ $-4.68 Million	-0.047x	-270.60%
2014-12-31	₩117.34 Billion ≈ $79.52 Million	₩-1.49 Billion ≈ $-1.01 Million	-0.013x	-229.63%
2011-12-31	₩115.04 Billion ≈ $77.96 Million	₩1.13 Billion ≈ $765.03K	0.010x	--

About MEDIPOST Co. Ltd

KQ:078160 Korea Biotechnology & Medical Research

Market Cap

$290.79 Million

₩429.10 Billion KRW

Market Cap Rank

#15094 Global

#557 in Korea

Share Price

₩27900.00

Change (1 day)

-0.36%

52-Week Range

₩8100.00 - ₩28000.00

All Time High

₩72522.12